RNF20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.211800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.432000E-01
Normal-vs-Stage2
2.356800E-01
Normal-vs-Stage3
2.113600E-02
Normal-vs-Stage4
9.062800E-01
Stage1-vs-Stage2
5.184000E-01
Stage1-vs-Stage3
7.120200E-02
Stage1-vs-Stage4
4.989200E-01
Stage2-vs-Stage3
7.083800E-02
Stage2-vs-Stage4
1.196990E-01
Stage3-vs-Stage4
6.092200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.131400E-01
Normal-vs-AfricanAmerican
2.233400E-01
Normal-vs-Asian
3.348000E-01
Caucasian-vs-AfricanAmerican
9.755200E-01
Caucasian-vs-Asian
9.280600E-01
AfricanAmerican-vs-Asian
9.231400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.546600E-01
Normal-vs-Female
2.964600E-01
Male-vs-Female
6.165600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.087200E-01
Normal-vs-Age(41-60Yrs)
5.453600E-01
Normal-vs-Age(61-80Yrs)
2.755400E-01
Normal-vs-Age(81-100Yrs)
8.531900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.686400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.197400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.192600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.927700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.267600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.890400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.633700E-02
Normal-vs-Daily Drinker
6.806100E-02
Normal-vs-Weekly Drinker
1.912390E-01
Normal-vs-Occasional Drinker
9.006800E-01
Normal-vs-Social Drinker
7.587400E-01
Non Drinker-vs-Daily Drinker
9.501800E-01
Non Drinker-vs-Weekly Drinker
5.004000E-01
Non Drinker-vs-Occasional Drinker
2.247900E-02
Non Drinker-vs-Social Drinker
2.574100E-02
Daily Drinker-vs-Weekly Drinker
4.813000E-01
Daily Drinker-vs-Occasional Drinker
2.281900E-02
Daily Drinker-vs-Social Drinker
3.232300E-02
Weekly Drinker-vs-Occasional Drinker
1.217360E-01
Weekly Drinker-vs-Social Drinker
1.884160E-01
Occasional Drinker-vs-Social Drinker
7.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.889800E-02
Normal-vs-Grade 2
2.112400E-02
Normal-vs-Grade 3
1.407940E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.187400E-01
Grade 1-vs-Grade 3
7.223600E-01
Grade 1-vs-Grade 4
7.889800E-02
Grade 2-vs-Grade 3
2.889200E-01
Grade 2-vs-Grade 4
2.112400E-02
Grade 3-vs-Grade 4
1.407940E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.857850E-01
Normal-vs-NonDiabetic
3.108800E-01
Diabetic-vs-NonDiabetic
3.909000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.362400E-01
Normal-vs-NoPancreatitis
3.035000E-01
Pancreatitis-vs-NoPancreatitis
7.274000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.392800E-01
Normal-vs-N1
2.416800E-01
N0-vs-N1
2.839600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.793400E-01
Normal-vs-TP53-NonMutant
6.798200E-01
TP53-Mutant-vs-TP53-NonMutant
4.116600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
